Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Graves

Orthopaedic Surgery Jackson, MS Medical Doctor

NPI 1891702148 CMS profile 40829

2500 N State St, Jackson, MS 39216

Open in the dashboard

General payments

$1,234,732

215 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Graves of Jackson, MS is reported in the CMS Open Payments database as having received $1,234,732 across 215 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $381,898 28
2024 General $206,777 24
2023 General $236,490 23
2022 General $181,960 27
2021 General $59,785 17
2020 General $91,645 33
2019 General $76,178 63

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Graves
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Matthew Graves were reported at $381,898. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Matthew Graves Orthopaedic Surgery median Middle half National median
2019 $76,178 $644 $140–$2,844 $163
2020 $91,645 $312 $75–$1,860 $114
2021 $59,785 $520 $117–$2,495 $132
2022 $181,960 $598 $128–$2,731 $149
2023 $236,490 $461 $128–$2,264 $160
2024 $206,777 $497 $134–$2,475 $164
2025 $381,898 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. DePuy Synthes Products, Inc. $1,046,820 32 payments
  2. Medical Device Business Services, Inc. $127,075 98 payments
  3. Synthes USA Products LLC $29,619 31 payments
  4. Synthes GmbH $26,439 32 payments
  5. Globus Medical, Inc. $1,811 5 payments
  6. Alon Medical Technology $1,200 1 payment
  7. DePuy Synthes Sales Inc. $800 10 payments
  8. Solventum Corporation $600 1 payment
  9. Stryker Corporation $222 1 payment
  10. Zimmer Biomet Holdings, Inc. $118 2 payments
  11. Other $29 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $1,046,305 31 payments
  2. Consulting Fee $146,940 36 payments
  3. Travel and Lodging $17,272 52 payments
  4. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $12,750 15 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $6,290 6 payments
  6. Food and Beverage $3,679 71 payments
  7. Education $1,495 4 payments
Products named General payments · program years 2019–2025
  1. NA Trauma $982,716 28 payments
  2. IM NAILS $98,178 30 payments
  3. NA Trauma $53,921 29 payments
  4. LCP PLATES & SCREWS $47,300 15 payments
  5. INSTRUMENTS $46,373 15 payments
  6. ORTHOPEDIC CABLE / PERIPROSTHETIC SYSTEM $37,821 10 payments
  7. DCP/LC-DCP PLATES & SCREWS $37,821 10 payments
  8. TFN ADVANCED $20,435 18 payments
  9. EX NAILS $20,168 11 payments
  10. DHS $18,946 7 payments
  11. Other $65,970 84 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

18

Median for Orthopedic Surgery: 203

Drug cost

$44

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 18 $44

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$16,279

Medicare's payments for the services billed

Medicare patients

46

Average age 69

Services billed

126

28 women, 18 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Osteoporosis 37%
Diabetes 33%
Depression 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

215 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record